PHASE 1 AND 2 TRIAL OF RUBIDAZONE IN PATIENTS WITH ACUTE-LEUKEMIA
- 1 January 1977
- journal article
- research article
- Vol. 37 (12), 4623-4628
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Adriamycin cardiomyopathy—risk factorsCancer, 1977
- PLASMA PHARMACOKINETICS OF ADRIAMYCIN AND ITS METABOLITES IN HUMANS WITH NORMAL HEPATIC AND RENAL-FUNCTION1977
- Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignanciesCancer, 1976
- RANDOMIZED CLINICAL COMPARISON OF DAUNORUBICIN (NSC-82151) ALONE WITH A COMBINATION OF DAUNORUBICIN, CYTOSINE-ARABINOSIDE (NSC-63878), 6-THIOGUANINE (NSC-752), AND PYRIMETHAMINE (NSC-3061) FOR TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA1976